XML 28 R11.htm IDEA: XBRL DOCUMENT v3.8.0.1
Restructuring Charges
 3 Months Ended
Dec. 30, 2017
Restructuring and Related Activities [Abstract]  
Restructuring Charges
Restructuring Charges
The Company evaluates its operations for opportunities to improve operational effectiveness and efficiency, including facility and operations consolidation, and to better align expenses with revenues. In addition, the Company continually assesses its management and organizational structure. As a result of these assessments, the Company has undertaken various restructuring actions, which are described below. The following table displays charges related to these actions recorded in the fiscal 2018 year to date period (three months ended December 30, 2017) and fiscal 2017 (the year ended September 30, 2017) and a rollforward of the accrued balances from September 30, 2017 to December 30, 2017:
 
 
Fiscal 2018 Actions
 
Fiscal 2017 Actions
 
Fiscal 2016 Actions
 
Total    
Restructuring Charges
 
 
 
 
 
 
 
 
Fiscal 2017 charges:
 
 
 
 
 
 
 

Workforce reductions
 
$
—

 
$
8.5

 
$
—

 
$
8.5

Facility closure costs
 
—

 
—

 
4.8

 
4.8

Fiscal 2017 restructuring charges
 
$
—

 
$
8.5

 
$
4.8

 
$
13.3

Fiscal 2018 charges:
 
 
 
 
 
 
 
 
Workforce reductions
 
$
3.8

 
$
—

 
$
—

 
$
3.8

Fiscal 2018 restructuring charges
 
$
3.8

 
$
—

 
$
—

 
$
3.8


 
 
Fiscal 2018 Actions
 
Fiscal 2017 Actions
 
Fiscal 2016 Actions
 
Other
 
Total    
Rollforward of Accrued Restructuring
 
 
 
 
 
 
 
 
 
 
Balance as of September 30, 2017
 
$
—

 
$
7.5

 
$
3.7

 
$
0.3

 
$
11.5

Fiscal 2018 charges
 
3.8

 
—

 
—

 
—

 
3.8

Stock-based compensation
 
(1.3
)
 
—

 
—

 
—

 
(1.3
)
Severance payments and adjustments
 
(0.9
)
 
(2.3
)
 
(0.2
)
 
—

 
(3.4
)
Other payments
 
—

 
—

 
(0.3
)
 
(0.1
)
 
(0.4
)
Balance as of December 30, 2017
 
$
1.6

 
$
5.2

 
$
3.2

 
$
0.2

 
$
10.2


Fiscal 2018 Actions
During the first quarter of fiscal 2018, the Company decided to terminate certain employees across the organization, including a corporate executive and sales and marketing personnel in its Diagnostics and Medical Aesthetics reportable segments. The charges were recorded pursuant to ASC 712, Compensation-Nonretirement Postemployment Benefits (ASC 712) or ASC 420, Exit or Disposal Cost Obligations (ASC 420) depending on the employee. As such, the Company recorded severance and benefits charges of $3.8 million in the first quarter. Included within this charge is $1.3 million related to the modification of equity awards.
Fiscal 2017 Actions
In connection with its acquisition of Cynosure, the Company decided to terminate certain Cynosure executives in the second quarter of fiscal 2017 and recorded $1.5 million in severance and benefits charges. During the third and fourth quarters of fiscal 2017, the Company terminated additional executives and employees and recorded $4.3 million and $1.3 million, respectively, in severance and benefits charges.
Fiscal 2016 Actions
In connection with the closure of the Bedford, Massachusetts facility, during the first quarter of fiscal 2017 the Company recorded $3.5 million for lease obligation charges related to a section of the facility that the Company had determined met the cease-use date criteria. The Company made certain assumptions regarding the time period it would take to obtain a subtenant and the sublease rates it can obtain. During the third quarter of fiscal 2017, the Company updated its assumption regarding the time period it will take to obtain a subtenant at the Bedford location and as a result recorded an additional $1.3 million lease obligation charge. These estimates may vary from the actual sublease agreements executed, if at all, resulting in an adjustment to the charge. The Company has vacated other portions of the building but not the entire facility, and at this time does not meet the cease-use date criteria to record additional restructuring charges.